Home / HRTX : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HRTX make money? Does HRTX have pricing power? What's the Earnings Whisper? Will HRTX profit more as the business scales? What is HRTX's management track record? Is HRTX's current price justified?

Heron Therapeutics, Inc.

$0.31 -$0.95 (-75.49%)

NASDAQ · 15 Sep 2026 14:51 UTC

Previous Close

$0.32

Day Range

$0.31$0.31

Year Range

$0.3$1.58

Market Cap

58.45M

AVG Volume

3.13M

Trailing/Forward PE

-1.65/-

PEG ratio

0.11

Dividend Yield

Next Earnings Date

2026-11-03

Primary Exchange

NASDAQ

Revenue (USD) · TTM

HRTX Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	151.18M
26 Q1	150.71M
25 Q4	154.9M
25 Q3	155.1M
25 Q2	149.69M
25 Q1	148.52M
24 Q4	144.28M
24 Q3	137.74M
24 Q2	136.36M
24 Q1	132.1M

Net Income (USD) · TTM

HRTX Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-34.05M
26 Q1	-30.94M
25 Q4	-20.2M
25 Q3	-13.58M
25 Q2	-931K
25 Q1	-7.79M
24 Q4	-13.58M
24 Q3	-27.97M
24 Q2	-48.13M
24 Q1	-80.95M

Operating Income (USD) · TTM

HRTX Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-10.86M
26 Q1	-10.46M
25 Q4	-2.54M
25 Q3	1.6M
25 Q2	1.23M
25 Q1	-3.58M
24 Q4	-11.53M
24 Q3	-25.92M
24 Q2	-46.39M
24 Q1	-82.35M

EBITDA (USD) · TTM

HRTX EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-27.84M
26 Q1	-24.12M
25 Q4	-12.86M
25 Q3	-3.33M
25 Q2	6.88M
25 Q1	459K
24 Q4	-5.13M
24 Q3	-19.45M
24 Q2	-39.4M
24 Q1	-72.53M

Cash Flows (USD) · TTM

HRTX Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-12.13M
26 Q1	-20.86M
25 Q4	-27.91M
25 Q3	-31.14M
25 Q2	-29.53M
25 Q1	-23.7M
24 Q4	-24.23M
24 Q3	-9.61M
24 Q2	-22.52M
24 Q1	-44.73M

EPS (USD) · TTM

HRTX EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.19
26 Q1	-0.18
25 Q4	-0.12
25 Q3	-0.08
25 Q2	-0.01
25 Q1	-0.05
24 Q4	-0.09
24 Q3	-0.18
24 Q2	-0.32
24 Q1	-0.61

Expenses (USD) · TTM

HRTX Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	117.33M
26 Q1	118.24M
25 Q4	116.41M
25 Q3	114M
25 Q2	111.85M
25 Q1	115.25M
24 Q4	118.87M
24 Q3	126.67M
24 Q2	137.38M
24 Q1	159.07M

Shares Outstanding (USD) · TTM

HRTX Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-11.04M
26 Q1	-10.8M
25 Q4	-10.34M
25 Q3	-10.46M
25 Q2	-10.32M
25 Q1	-12.1M
24 Q4	-12.96M
24 Q3	-14.99M
24 Q2	-18.95M
24 Q1	-28.28M

Employee Count

HRTX Employee Count by quarter
Period	Employee Count
2025	128
2024	122
2023	126
2022	203
2021	302
2020	223
2019	231
2018	198
2017	145
2016	139

Free Cash Flow Yield

HRTX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-20.22%
Sep 26	-20.21%
Sep 26	-18.54%
Aug 26	-19.52%
Aug 26	-20.04%
Aug 26	-18.94%
Aug 26	-22.41%
Jul 26	-22.17%
Jul 26	-24.13%
Jul 26	-23.37%
Jul 26	-26.54%
Jul 26	-25.09%
Jun 26	-25.58%
Jun 26	-26.35%
Jun 26	-27.49%
Jun 26	-25.74%
May 26	-12.64%
May 26	-12.81%
May 26	-12.94%
May 26	-13.84%
May 26	-13.18%
Apr 26	-14.07%
Apr 26	-16.74%
Apr 26	-19.63%
Apr 26	-20.95%
Mar 26	-21.36%
Mar 26	-21.5%
Mar 26	-18.99%
Mar 26	-17.32%
Feb 26	-14.07%
Feb 26	-15.49%
Feb 26	-15.9%
Feb 26	-14.51%
Jan 26	-13.85%
Jan 26	-12.87%
Jan 26	-12.27%
Jan 26	-13.15%
Jan 26	-14.51%
Dec 25	-14.28%
Dec 25	-14.06%
Dec 25	-13.34%
Dec 25	-13.96%
Nov 25	-15.76%
Nov 25	-17.25%
Nov 25	-16.62%
Nov 25	-16.62%
Oct 25	-16.53%
Oct 25	-15.98%
Oct 25	-14.86%
Oct 25	-14.98%
Oct 25	-14.53%
Sep 25	-15.85%
Sep 25	-15.59%
Sep 25	-15.22%
Sep 25	-14.64%
Aug 25	-14.2%
Aug 25	-13.7%
Aug 25	-14.42%
Aug 25	-14.53%
Aug 25	-9.14%
Jul 25	-8.08%
Jul 25	-8%
Jul 25	-7.08%
Jul 25	-7.02%
Jun 25	-7.21%
Jun 25	-7.72%
Jun 25	-8%
Jun 25	-7.35%
May 25	-8.21%
May 25	-8.35%
May 25	-7.84%
May 25	-7.32%
May 25	-6.85%
Apr 25	-6.88%
Apr 25	-8.6%
Apr 25	-8.28%
Apr 25	-7.54%
Mar 25	-7%
Mar 25	-6.65%
Mar 25	-6.82%
Mar 25	-6.62%
Feb 25	-6.41%
Feb 25	-3.64%
Feb 25	-3.53%
Feb 25	-3.61%
Jan 25	-3.7%
Jan 25	-3.44%
Jan 25	-3.86%
Jan 25	-4.06%
Jan 25	-3.79%
Dec 24	-4.06%
Dec 24	-3.98%
Dec 24	-3.93%
Dec 24	-3.88%
Nov 24	-5.29%
Nov 24	-5.88%
Nov 24	-5.29%
Nov 24	-8.45%
Nov 24	-8.31%
Oct 24	-7.99%

Price to Sales

HRTX Price to Sales by quarter
Period	Price to Sales
Sep 26	0.4
Sep 26	0.4
Sep 26	0.43
Aug 26	0.41
Aug 26	0.4
Aug 26	0.42
Aug 26	0.62
Jul 26	0.62
Jul 26	0.57
Jul 26	0.59
Jul 26	0.52
Jul 26	0.55
Jun 26	0.54
Jun 26	0.53
Jun 26	0.5
Jun 26	0.54
May 26	1.09
May 26	1.08
May 26	1.07
May 26	1.3
May 26	1.37
Apr 26	1.28
Apr 26	1.08
Apr 26	0.92
Apr 26	0.86
Mar 26	0.84
Mar 26	0.84
Mar 26	0.95
Mar 26	1.04
Feb 26	1.28
Feb 26	1.3
Feb 26	1.26
Feb 26	1.38
Jan 26	1.45
Jan 26	1.56
Jan 26	1.64
Jan 26	1.53
Jan 26	1.38
Dec 25	1.41
Dec 25	1.43
Dec 25	1.5
Dec 25	1.44
Nov 25	1.27
Nov 25	1.16
Nov 25	1.21
Nov 25	1.21
Oct 25	1.19
Oct 25	1.23
Oct 25	1.33
Oct 25	1.32
Oct 25	1.36
Sep 25	1.24
Sep 25	1.27
Sep 25	1.3
Sep 25	1.35
Aug 25	1.39
Aug 25	1.44
Aug 25	1.37
Aug 25	1.36
Aug 25	1.75
Jul 25	1.97
Jul 25	1.99
Jul 25	2.25
Jul 25	2.27
Jun 25	2.21
Jun 25	2.07
Jun 25	1.99
Jun 25	2.17
May 25	1.94
May 25	1.91
May 25	2.04
May 25	2.18
May 25	2.45
Apr 25	2.44
Apr 25	1.95
Apr 25	2.03
Apr 25	2.23
Mar 25	2.4
Mar 25	2.53
Mar 25	2.46
Mar 25	2.54
Feb 25	2.62
Feb 25	1.92
Feb 25	1.98
Feb 25	1.93
Jan 25	1.89
Jan 25	2.03
Jan 25	1.81
Jan 25	1.72
Jan 25	1.84
Dec 24	1.72
Dec 24	1.75
Dec 24	1.78
Dec 24	1.8
Nov 24	1.32
Nov 24	1.19
Nov 24	1.32
Nov 24	1.95
Nov 24	1.99
Oct 24	2.07

EV/EBITDA

HRTX EV/EBITDA by quarter
Period	EV/EBITDA
Oct 25	45.73
Oct 25	46.63
Oct 25	48.64
Oct 25	48.42
Oct 25	49.31
Sep 25	46.85
Sep 25	47.3
Sep 25	47.97
Sep 25	49.09
Aug 25	49.98
Aug 25	51.1
Aug 25	49.54
Aug 25	49.31
Aug 25	840.9
Jul 25	914.47
Jul 25	921.16
Jul 25	1004.76
Jul 25	1011.45
Jun 25	991.38
Jun 25	944.57
Jun 25	921.16
Jun 25	978.01
May 25	904.44
May 25	894.41
May 25	934.54
May 25	981.35

Price to Book

HRTX Price to Book by quarter
Period	Price to Book
Sep 26	8.69
Sep 26	8.69
Sep 26	9.48
Aug 26	9
Aug 26	8.77
Aug 26	9.28
Aug 26	10.19
Jul 26	10.3
Jul 26	9.46
Jul 26	9.77
Jul 26	8.6
Jul 26	9.1
Jun 26	8.93
Jun 26	8.67
Jun 26	8.3
Jun 26	8.87
May 26	18.06
May 26	17.83
May 26	17.64
May 26	14.07
May 26	14.77
Apr 26	13.84
Apr 26	11.63
Apr 26	9.92
Apr 26	9.3
Mar 26	9.12
Mar 26	9.06
Mar 26	10.26
Mar 26	11.24
Feb 26	13.84
Feb 26	13.5
Feb 26	13.16
Feb 26	14.42
Jan 26	15.11
Jan 26	16.25
Jan 26	17.05
Jan 26	15.91
Jan 26	14.42
Dec 25	14.65
Dec 25	14.88
Dec 25	15.68
Dec 25	14.99
Nov 25	13.28
Nov 25	12.13
Nov 25	12.59
Nov 25	12.59
May 23	21.69
Apr 23	20.98
Apr 23	24.23
Apr 23	23.97
Apr 23	20.02
Mar 23	13.26
Mar 23	9.48
Mar 23	11.55
Mar 23	10.75
Mar 23	11.9
Feb 23	11.35
Feb 23	13.44
Feb 23	13.09
Feb 23	14.13
Jan 23	13.89
Jan 23	14.68
Jan 23	15.78
Jan 23	12.54
Dec 22	12.44
Dec 22	12.79
Dec 22	13.64
Dec 22	13.34
Dec 22	13.74
Nov 22	14.28
Nov 22	14.73
Nov 22	17.12
Aug 22	13.73
Jul 22	11.85
Jul 22	11.64
Jul 22	12.53
Jul 22	14.11
Jul 22	11.59
Jun 22	14.49
Jun 22	11.81
Jun 22	9.85
Jun 22	12.79
May 22	14.32
May 22	15.35
May 22	15.3
May 22	5.4
Apr 22	5.94
Apr 22	6.78
Apr 22	7.72
Apr 22	7.66
Apr 22	7.95
Mar 22	7.23
Mar 22	7.23
Mar 22	6.52
Mar 22	6.98
Feb 22	6.47
Feb 22	6.34
Feb 22	7.52
Feb 22	7.32
Jan 22	6.99

No video analysis for this stock yet. Request one from our team.

News: HRTX

seekingalpha.com · 10 Aug 2026

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

zacks.com · 10 Aug 2026

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago.

marketbeat.com · 10 Aug 2026

Heron Therapeutics Q2 Earnings Call Highlights

Heron Therapeutics NASDAQ: HRTX reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management said sales of its key products came in below its internal expectations.

globenewswire.com · 27 Jul 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

CARY, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, August 10, 2026, at 8:30 a.m. ET to report second quarter financial results and discuss recent business highlights.

zacks.com · 15 Jul 2026

New Strong Sell Stocks for July 15th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.